InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Discover the complete record of transactions filed by Yale Catriona, Chief Development Officer. Insider active across 1 companies, notably Akero Therapeutics, Inc.. Aggregated, 10 disclosures have been logged. Total volume traded: €1.6m. The latest transaction was filed on 15 October 2021 — Cession. Regulator: SEC (Form 4). The full history is openly available.
Declarations10 total
27,227 shares
Common Stock
SEC:0001193125-25-312100·
27,227 shares
Common Stock
SEC:0001193125-25-312100:0·
€230,85212,400 shares@ €18.617129.4% of flow
Common Stock
SEC:0001104659-21-127182·
€230,85212,400 shares@ €18.617114.7% of flow
Common Stock
SEC:0001104659-21-127182:0·
€218,26210,500 shares@ €20.786827.8% of flow
Common Stock
SEC:0001104659-21-116899·
€218,26210,500 shares@ €20.786813.9% of flow
Common Stock
SEC:0001104659-21-116899:0·
€159,50810,000 shares@ €15.950820.3% of flow
Common Stock
SEC:0001104659-21-107125·
€159,50810,000 shares@ €15.950810.2% of flow
Common Stock
SEC:0001104659-21-107125:0·
€176,97910,000 shares@ €17.697922.5% of flow
Common Stock
SEC:0001104659-21-093493·
€176,97910,000 shares@ €17.697911.3% of flow
Common Stock
SEC:0001104659-21-093493:0·
10 of 10 declarations
About Yale Catriona
Catriona Yale is the Chief Development Officer at Akero Therapeutics, Inc. She is responsible for product development strategy and growth initiatives for the company. Her expertise in the pharmaceutical sector enables her to lead innovative projects and contribute to the advancement of therapeutic treatments.
